Drug patent expiry reduces costs by prompting a switch to generic drugs

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.492, 2005-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Generic drug sales continue to flourish in France, assisted by a favourable regulatory regime and a surge of patent expiries for leading drugs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 474, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

How much is patent protection threatened by drug costs?

By Loff Bebe

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 9, 2004-09 ,pp. : 1863-1865

Informa Healthcare

Access to resources Recommend Favorite

Loss of bodyweight reduces drug use, costs in obesity

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Buprenorphine/naloxone reduces drug abuse, costs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 552, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

OTC omeprazole, amlodipine patent expiry affects US markets

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 464, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite